{"id":"https://openalex.org/W1979935271","doi":"https://doi.org/10.15583/jpchrom.2015.003","title":"Simultaneous Analysis of Oral Antidiabetic Drug by LC-MS/MS","display_name":"Simultaneous Analysis of Oral Antidiabetic Drug by LC-MS/MS","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W1979935271","doi":"https://doi.org/10.15583/jpchrom.2015.003","mag":"1979935271"},"language":"en","primary_location":{"id":"doi:10.15583/jpchrom.2015.003","doi":"https://doi.org/10.15583/jpchrom.2015.003","is_oa":true,"landing_page_url":"https://doi.org/10.15583/jpchrom.2015.003","pdf_url":"https://www.jstage.jst.go.jp/article/jpchrom/36/1/36_2015.003/_pdf","source":{"id":"https://openalex.org/S4210188149","display_name":"Chromatography","issn_l":"1342-8284","issn":["1342-8284","1348-3315"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CHROMATOGRAPHY","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jpchrom/36/1/36_2015.003/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071665793","display_name":"Shigemi Kai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104113","display_name":"Kanagawa Prefectural Institute of Public Health","ror":"https://ror.org/016c9ds94","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210104113"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigemi KAI","raw_affiliation_strings":["Kanagawa Prefectural Institute of Public Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanagawa Prefectural Institute of Public Health","institution_ids":["https://openalex.org/I4210104113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035810377","display_name":"Ken Ishikawa","orcid":"https://orcid.org/0000-0001-7585-1182","observed_orcids":["https://orcid.org/0000-0001-7585-1182"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ken ISHIKAWA","raw_affiliation_strings":["Faculty of Pharmacy, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109085278","display_name":"Ito Hajime","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hajime ITO","raw_affiliation_strings":["Faculty of Pharmacy, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103118338","display_name":"Tatsuya Ogawa","orcid":"https://orcid.org/0000-0001-6448-9747","observed_orcids":["https://orcid.org/0000-0001-6448-9747"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuya OGAWA","raw_affiliation_strings":["Faculty of Pharmacy, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087233126","display_name":"Hidetaka Yamashita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidetaka YAMASHITA","raw_affiliation_strings":["Faculty of Pharmacy, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038241333","display_name":"Yoshiko Nagata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiko NAGATA","raw_affiliation_strings":["Faculty of Pharmacy, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University","institution_ids":["https://openalex.org/I203951103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067992625","display_name":"Hideko Kanazawa","orcid":"https://orcid.org/0000-0003-2550-470X","observed_orcids":["https://orcid.org/0000-0003-2550-470X"]},"institutions":[{"id":"https://openalex.org/I203951103","display_name":"Keio University","ror":"https://ror.org/02kn6nx58","country_code":"JP","type":"education","lineage":["https://openalex.org/I203951103"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideko KANAZAWA","raw_affiliation_strings":["Faculty of Pharmacy, Keio University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmacy, Keio University","institution_ids":["https://openalex.org/I203951103"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1757,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.42769552,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"36","issue":"1","first_page":"19","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.8163999915122986,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.8163999915122986,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10419","display_name":"Pharmaceutical and Antibiotic Environmental Impacts","score":0.05299999937415123,"subfield":{"id":"https://openalex.org/subfields/2310","display_name":"Pollution"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11423","display_name":"Pesticide Residue Analysis and Safety","score":0.04780000075697899,"subfield":{"id":"https://openalex.org/subfields/1106","display_name":"Food Science"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-antidiabetic-drugs","display_name":"oral antidiabetic drugs","score":0.9890000224113464},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9520000219345093},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8360000252723694},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.6740000247955322},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9879999756813049},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":1.0},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":1.0},{"id":"https://openalex.org/keywords/simultaneous-drug-analysis","display_name":"simultaneous drug analysis","score":0.6449999809265137},{"id":"https://openalex.org/keywords/river-pollution","display_name":"river pollution","score":0.8550000190734863},{"id":"https://openalex.org/keywords/lc-ms-ms","display_name":"LC-MS/MS","score":0.9200000166893005}],"concepts":[{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.9636273384094238},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.9259511232376099},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.7533667087554932},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.7005656361579895},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6677651405334473},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.5995725989341736},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.5275135636329651},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5249207615852356},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5042001008987427},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4959655702114105},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.46031567454338074},{"id":"https://openalex.org/C40684141","wikidata":"https://www.wikidata.org/wiki/Q902061","display_name":"Electrospray ionization","level":3,"score":0.45946288108825684},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4456779658794403},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.440518856048584},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.4378664493560791},{"id":"https://openalex.org/C64489805","wikidata":"https://www.wikidata.org/wiki/Q873864","display_name":"Liquid chromatography\u2013mass spectrometry","level":3,"score":0.4161708950996399},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3371933102607727},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.17383426427841187},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.11075598001480103},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08524718880653381},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.15583/jpchrom.2015.003","doi":"https://doi.org/10.15583/jpchrom.2015.003","is_oa":true,"landing_page_url":"https://doi.org/10.15583/jpchrom.2015.003","pdf_url":"https://www.jstage.jst.go.jp/article/jpchrom/36/1/36_2015.003/_pdf","source":{"id":"https://openalex.org/S4210188149","display_name":"Chromatography","issn_l":"1342-8284","issn":["1342-8284","1348-3315"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CHROMATOGRAPHY","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.15583/jpchrom.2015.003","doi":"https://doi.org/10.15583/jpchrom.2015.003","is_oa":true,"landing_page_url":"https://doi.org/10.15583/jpchrom.2015.003","pdf_url":"https://www.jstage.jst.go.jp/article/jpchrom/36/1/36_2015.003/_pdf","source":{"id":"https://openalex.org/S4210188149","display_name":"Chromatography","issn_l":"1342-8284","issn":["1342-8284","1348-3315"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CHROMATOGRAPHY","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1979935271.pdf","grobid_xml":"https://content.openalex.org/works/W1979935271.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1685699583","https://openalex.org/W2010432556","https://openalex.org/W2012852892","https://openalex.org/W2019346626","https://openalex.org/W2020380758","https://openalex.org/W2053322034","https://openalex.org/W2061223959","https://openalex.org/W2104288577","https://openalex.org/W2152356295","https://openalex.org/W2328107407"],"related_works":["https://openalex.org/W3003694638","https://openalex.org/W4362506760","https://openalex.org/W7140034476","https://openalex.org/W2332461843","https://openalex.org/W2947107228","https://openalex.org/W2901381754","https://openalex.org/W4409118408","https://openalex.org/W6930887260","https://openalex.org/W4311161369","https://openalex.org/W1975571132"],"abstract_inverted_index":{"Diabetes":[0],"is":[1,33],"one":[2],"of":[3,27,30,56,72,116],"the":[4,105,114],"most":[5],"common":[6],"chronic":[7],"diseases,":[8],"and":[9,58,111,133],"several":[10],"new":[11,70],"oral":[12,73],"agents":[13,32],"have":[14],"been":[15],"approved":[16,128],"for":[17],"type":[18],"2":[19],"diabetes":[20],"management":[21],"in":[22,48,108,119,137],"recent":[23],"years.":[24],"A":[25,44],"combination":[26,47,55,109],"different":[28],"classes":[29],"antidiabetic":[31,74,83,117,129],"often":[34],"required":[35],"to":[36,103,112],"avoid":[37],"adverse":[38],"effects":[39],"such":[40],"as":[41],"severe":[42],"hypoglycemia.":[43],"potential":[45],"novel":[46],"development":[49],"involves":[50],"a":[51,59,68],"fixed":[52],"dose":[53],"single-tablet":[54],"pioglitazone":[57],"dipeptidyl":[60],"peptidase":[61],"4":[62],"(DPP-4)":[63],"inhibitor.":[64],"DPP-4":[65,88],"inhibitors":[66],"are":[67,135],"relatively":[69],"class":[71],"drugs.":[75],"In":[76],"this":[77],"study,":[78],"we":[79],"simultaneously":[80],"analyzed":[81],"eight":[82],"drugs,":[84,130],"including":[85],"newly":[86],"developed":[87,99],"inhibitors,":[89],"by":[90],"high-performance":[91],"liquid":[92],"chromatography\u2013electrospray":[93],"ionization\u2013tandem":[94],"mass":[95],"spectrometry":[96],"(HPLC\u2013ESI\u2013MS/MS).":[97],"The":[98],"method":[100],"was":[101],"applied":[102],"analyze":[104],"active":[106],"ingredients":[107],"drugs":[110,118],"determine":[113],"concentration":[115],"river":[120,138],"water.":[121,139],"Our":[122],"results":[123],"indicate":[124],"that":[125],"three":[126],"recently":[127],"sitagliptin,":[131],"alogliptin,":[132],"vildagliptin,":[134],"present":[136]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}